Metech International: Major Strategic Shifts, Subsidiary Disposals, and Key Financing Negotiations Signal New Era

Key Points for Investors

• Pending Appointment of New Chief Financial Officer – Candidate identified; internal due diligence ongoing.
• Potential Exit from Lab-Grown Diamond Business – Proposed sale of 80% stake in Asian Eco Technology Pte. Ltd. to Wuhan Xilu Trading Co., Ltd.
• Developments in Food Waste and Health Supplements Businesses – Progress in machinery import, new product discussions, and potential strategic partnerships.
• Restructuring via Subsidiary Disposal/Strike-Off – Ongoing negotiations to divest or strike off dormant or non-core subsidiaries in China and Singapore.
• Outstanding S\$1.37 Million Loan Negotiation – Company in talks for repayment or potential debt capitalisation with major lender.

Detailed Analysis: Major Developments and Potential Share Price Catalysts

1. Leadership Transition: CFO Appointment Under Review

Metech International has shortlisted a candidate for the vital post of Chief Financial Officer (CFO) and is now conducting internal due diligence. The company will submit the necessary documentation to its continuing sponsor for further assessment. Investors should note that a new CFO could signal fresh strategic direction and improved governance, potentially impacting investor confidence and share price upon confirmation of the appointment.

2. Strategic Exit from Lab-Grown Diamond Business

In a significant move, Metech has proposed to fully divest its 80% stake in Asian Eco Technology Pte. Ltd. (its lab-grown diamond subsidiary) to Wuhan Xilu Trading Co., Ltd. This proposed disposal is currently under SGX Catalist Rule 1014 review. The company intends to seek a waiver for holding an EGM (Extraordinary General Meeting) to gain shareholder approval, which, if granted and executed, would mark a major shift in Metech’s operational focus. This is a price-sensitive action, as it could result in a substantial change in the company’s asset base, business risk profile, and future earnings streams. Shareholders should watch for further announcements regarding regulatory approvals and transaction finalisation.

3. Expansion and Partnerships in Food Waste and Health Supplement Businesses

• Food Waste Business: The company’s biomass carbon reduction systems have cleared customs and are en route for factory testing and commissioning. While macroeconomic uncertainties persist, Metech is taking a cautious yet optimistic stance, emphasizing long-term growth and risk management.
• Strategic Partnerships: Ongoing discussions with Burpple 2021 Pte. Ltd. could lead to collaborative opportunities, including strategic investments or partnerships, especially in the health supplements segment. This could open new revenue channels and strengthen business diversification.
• MLF Ingredients Collaboration: Metech remains in talks with MLF Ingredients Sdn. Bhd. to finalise pricing for premium protein powder and black soldier fly biomass products targeting South Korea and US markets. These could be new product launches, potentially enhancing revenue streams and market presence.
• Health Supplements Expansion: A supplier in China has obtained a health supplement license, and Metech is now discussing increased production capacity and ramping up marketing efforts to drive segment growth.

Collectively, these developments could be significant for the company’s revenue and growth trajectory, especially if partnerships or new product launches are successfully realised.

4. Subsidiary Restructuring and Divestment Plans

• China Operations: Metech is negotiating the sale of Zhongxin Minghua (Shanghai) International Trade Co., Ltd. (ZXMH), its wholly-owned PRC subsidiary, in response to complex business conditions and as part of a broader restructuring strategy.
• Dormant Entity in Singapore: Metech Dynamics Pte. Ltd. (MDY), a dormant Singapore subsidiary, is under review for possible disposal or strike-off.

These actions are aimed at streamlining operations, reducing costs, and sharpening strategic focus, potentially improving the group’s financial health and profitability.

5. Critical Loan Repayment Negotiations

Metech currently has S\$1.37 million outstanding on a S\$3 million interest-free loan from major lender Mr. Cao Shixuan, which matured on 6 October 2025. The company is actively negotiating a repayment plan that may include partial debt capitalisation or a maturity extension. The outcome could materially affect Metech’s balance sheet, gearing, and liquidity, making this a key event for shareholders to monitor.

What Should Shareholders Watch For?

• Formal announcement of CFO appointment.
• Updates on the lab-grown diamond business disposal—especially regulatory approvals or waiver decisions.
• Confirmation of new product launches, strategic partnerships, and investments in food waste and health supplement businesses.
• Finalisation of subsidiary disposals/strike-off processes, particularly in China.
• Resolution of the outstanding S\$1.37 million loan—terms of repayment or capitalisation could affect the company’s financial position and market sentiment.

Conclusion

Metech International is at a pivotal juncture, with multiple strategic decisions underway that could materially alter its business profile, risk exposure, and future prospects. Each of these developments holds the potential to move the share price, making it an important period for existing and prospective investors to stay alert to company announcements in the coming months.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult professional advisers before making investment decisions.

View Metech Intl Historical chart here